Table 1.
Item | Agreement K (95% CI) | Interpretation [8] | 0 point difference c | ±1 point difference c | > ±2 points difference c |
---|---|---|---|---|---|
Representativeness of the exposed cohort |
0.03 (−0.10, 0.15) |
Slight |
43 (66.2%) |
22 (33.8%) |
0 (0%) |
Selection of the non-exposed cohort |
0.00 (0.00, 0.00) |
Slight |
53 (81.5%) |
12 (18.5%) |
0 (0%) |
Ascertainment of exposure |
−0.02 (−0.08, 0.04) |
Poor |
12 (18.5%) |
53 (81.5%) |
0 (0%) |
Demonstration that outcome of interest was not present at start of study |
0.09 (−0.16, 0.35) |
Slight |
47 (72.3%) |
18 (27.7%) |
0 (0%) |
Comparability |
0.00a (−0.11, 0.12) |
Slight |
38 (58.5%) |
18 (27.7%) |
9 (13.8%) |
Assessment of outcome |
−0.04 (−0.09, 0.00) |
Poor |
59 (90.8%) |
6 (9.2%) |
0 (0%) |
Was follow-up long enough for outcomes to occur |
−0.06 (−0.22, 0.10) |
Poor |
31 (47.7%) |
34 (52.3%) |
0 (0%) |
Adequacy of follow-up of cohorts |
0.15 (−0.19, 0.48) |
Slight |
57 (87.7%) |
8 (12.3%) |
0 (0%) |
Total NOS score |
−0.004a (−0.11, 0.11) |
Poor |
15 (23.1%) |
20 (30.8%) |
30 (46.1%) |
Total categorized NOS score | 0.14b (−0.02, 0.29) | Slight | 44 (67.7%) | 21 (32.3%) | 0 (0%) |
Abbreviation: 95% CI = 95% confidence interval.
aLinear weighted kappa was used for both Comparability and Total NOS score; other kappas were not weighted (i.e., Cohen’s kappa was applied).
bQuadratic weighted kappa was used assuming the difference between very high risk, high risk and low risk were comparably unequal.
cNumber of studies with a 0, ±1, or more than ±2 points difference between reviewer and author assessments, separated by item.